The brain has always been the most intriguing part of the body. The diseases and conditions related to the brain have been a mystery for a very long time, even though significant advancements have been made in neuroscience. There is collaborative work to find solutions for debilitating diseases that affect the body's central nervous system. Stellixir Biotech team is well-equipped with the best infrastructure and research scientists. We help our clients with several services to develop therapies and bring substantial weightage to your research program.
Neurodegenerative diseases are severely debilitating conditions characterized primarily by progressive neuronal loss and impairment of the nervous system. Alzheimer's and Parkinson's diseases are the most common neurodegenerative disorders, and their impact is increasing as average life expectancy increases worldwide. Cell models that resemble the characteristics of the disease are important in drug discovery projects because they provide information about the therapeutic benefits of drugs under development. At Stellixir, we provide in vitro cell models to study the molecular basis of Alzheimer's and Parkinson's disease focusing on their potential for discovering of disease-modifying therapeutics to combat neurodegenerative diseases. We also offer phenotypic screening as an important approach for identifying novel therapeutic molecules. Our cell-based assays for drug discovery ranges from simple monoculture cell models to high-throughput three-dimensional cell models.
Neuroinflammation is now recognized as a critical process in different neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis, etc... Astrocytes and microglia are key players in neuroinflammation since they release wide variety of proinflammatory mediators, including nitric oxide, cytokines and chemokines. Target validation, complex cellular screening, mechanism of action studies and early translational biology research complete the breadth of activities performed by the Stellixir team in in vitro cell based models and assays.
Techniques Used: Flow Cytometry, Confocal/Fluorescence Microscopy (Multi-colour Immunofluorescence), ELISA (Fluorimetry/Colorimetry), RTqPCR, WB.